期刊文献+

非抗心律失常药物致QT延长和尖端扭转型室性心动过速的机理和相关危险因素 被引量:3

QT Prolongation and Torsades de Pointes Induced by Non-Antiarrhythmia Drugs:the Mechanism and Related Risk Factors
下载PDF
导出
摘要 临床上常用的一些非抗心律失常药物如抗菌素和抗组胺类药物也可导致QT间期延长甚至尖端扭转型室性心动过速。主要机理与抑制心肌细胞快速激活延迟整流钾电流相关。正常情况下发生概率极低,但当存在各种危险因素时发生率明显增高。主要的危险因素包括基因的易感性如存在亚临床型先天性QT延长综合征或基因的变异、合并用药、老年、女性、低血钾、严重心动过缓、基础心脏疾病和肝肾功能异常等。正确认识其发生机理和相关危险因素,可保证临床医师有效而安全地使用药物。 Some of the non-antiarrhythmia drugs,like antibiotics and antihistamines,can cause QT prolongation and torsades de pointes.It is rare but potentially fatal.The blockade of the rapid component of the delayed rectifier potassium current(IKr) of the cardiac cell is responsible for the cellular mechanisms of this action.The underlying risk factors include genetic susceptibility(Iatent congenital LQTS,genetic polymorphisms),drugs and drug combinations,advanced age,female sex,low serum potassium concentration,bradycardia,pre-existing cardiac disease,kidney and hepatic malfunction.Recognition of the related risk factors and exacerbating conditions can prevent the occurrence of the fatal side effect of these drugs.
出处 《心血管病学进展》 CAS 2011年第2期184-187,共4页 Advances in Cardiovascular Diseases
关键词 非抗心律失常药物 QT延长 机理 危险因素 non-antiarrhythmia drugs QT prolongation mechanism risk factors
  • 相关文献

参考文献18

  • 1Daprfi B. Spectrum of drugs prolonging QT interval and the incidence of torsode de pointes[J]. Eur Heart J, 2001, 3(suppl) : k70-k80.
  • 2Sanguinetti MC, Tristani-Firouzi M. hERG potassium channel and cardiac arrhythmia[J]. Nature, 2006, 440: 463469.
  • 3Yan GX, Wu Y, Liu T, et al. Phase 2 early after depolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventric:ular wall[ J]. Circu- lation, 2001, 103 : 2851-2856.
  • 4Akar FG, Yan GX, Antzelevitch C, et al. Unique topographical distribution ofM cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome[J]. Circulation, 2002, 105: 1247-1253.
  • 5Viskin S, Justo D, Hakin A, et al. Long QT syndrome caused by noncardiae dnugs[J]. Prog Cardiovasc Dis, 2003, 45: 415-427.
  • 6Drew BJ, Ackennan MJ, Funk M, et ah Prevention of torsade de pointes in hospital settings : a scientific statement from the American Heart Association and the American College of Cardiology Foundation [ J ]. Circulation, 2010, 121 : 1047-1060.
  • 7Roden MD. Drug induced prolongation of the QT interval[J]. N Engl J Med, 2004, 350: 1013-1022.
  • 8茹建华,吴伯镛.细胞色素P_(450)酶与用药选择[J].医药导报,2005,24(3):241-242. 被引量:6
  • 9Katritsis D, Camm AJ. Quinolones: cardioprotective or cardiotoxic[ J]. Pacing Clin Electrophysiol, 2003, 26(12) : 2317-2320.
  • 10Straehan EM, Kelly CA, Bateman DN. Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning[ J]. Eur J Clin Pharma- col, 2004, 60: 541-545.

二级参考文献8

  • 1袁浩龙.新型抗抑郁药与细胞色素 P450 系统[J].国外医学(精神病学分册),1997,24(1):39-43. 被引量:10
  • 2前崎繁文 河野茂.抗真菌药[J].综合临床,1999,48(12):1465-1465.
  • 3Gregg C R. Druginteractions and anti-infectivetherapies[J].Am J Med,1999,106(2):227.
  • 4Martinez C, Albet C, Agundez J A G, et al. Comparative in vitro and in vivo inhibition of cytochrome P450CYP1A2, CYP2D6 and CYP3A by H2-receptor antagonists[J]. Clin Pharmacol Ther, 1999,65(3) :369 -370.
  • 5Yasuda S, Horai Y, Tomono Y, et al. Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor,and omeprazole in relation to S-mephenytoin 4' -hydroxylation status[J].Clin Pharmacol Ther,1995,58(2) :143 - 154.
  • 6Lilja J J, Kivisto K T, Neuvonen P j. Grapefruit juice increases serum concentrations of atrovastatin and has no effect on pravastatin [J].Clin Pharmacol Ther, 1999,66 ( 1 ): 118.
  • 7Caraco Y, Tateishi T, Wood A J. Interethnic difference in omeprazole's inhibition of diazepam metabolism [J]. Clin Pharmacol Ther, 1995,58(1) :62 -72.
  • 8孙忠实.抗组胺药物的进展[J].中国新药杂志,1999,8(7):448-450. 被引量:34

共引文献5

同被引文献27

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部